Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,973 | 0 | 966 | 1,528 | 1,225 |
| Gross Profit | 2,973 | N/A | 966 | 1,528 | 1,225 |
| Operating Expenses | 12,729 | 11,914 | 11,194 | 11,107 | 11,561 |
| Operating Income | -9,756 | -11,914 | -10,228 | -9,579 | -10,336 |
| Interest Expense | 2,923 | 2,718 | 1,820 | 1,450 | 1,176 |
| Other Income | 7,198 | 23,618 | -12,973 | -8,818 | -19,649 |
| Pre-tax Income | -5,481 | 8,986 | -25,021 | -19,847 | -31,161 |
| Net Income Continuous | -5,481 | 8,986 | -25,021 | -19,847 | -31,161 |
| Net Income | $-5,481 | $8,986 | $-25,021 | $-19,847 | $-31,161 |
| EPS Basic Total Ops | -0.15 | 0.25 | -0.69 | -0.55 | -0.86 |
| EPS Basic Continuous Ops | -0.15 | 0.25 | -0.69 | -0.55 | -0.86 |
| EPS Diluted Total Ops | -0.15 | 0.25 | -0.69 | -0.48 | -0.86 |
| EPS Diluted Continuous Ops | -0.15 | 0.15 | -0.69 | -0.59 | -0.86 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.65 | -0.69 | -0.55 | -0.31 |
| EBITDA(a) | $-9,443 | $-11,599 | $-9,911 | $-9,286 | $-10,115 |